Page last updated: 2024-11-02

pamidronate and Calcinosis

pamidronate has been researched along with Calcinosis in 26 studies

Calcinosis: Pathologic deposition of calcium salts in tissues.

Research Excerpts

ExcerptRelevanceReference
"Juvenile dermatomyositis is a rare systemic autoimmune disease wth calcinosis as its hallmark sequelae."5.56Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis. ( Dash, M; Giri, S; Panda, M; Parida, JR, 2020)
"A 7-year-old girl with juvenile dermatomyositis developed severe calcinosis, despite an extensive medication regimen."5.40Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. ( Martillotti, J; Moote, D; Zemel, L, 2014)
"A 14-year-old girl with juvenile dermatomyositis developed extensive and debilitating calcinosis, unresponsive to colchicine, while muscle involvement subsided."5.36Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. ( Abdessemed, A; Haddouche, A; Ladjouze-Rezig, A; Slimani, S, 2010)
"Treatment with pamidronate resulted in only a slight enhancement of mineralization."2.84Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation. ( Blouin, S; Fratzl-Zelman, N; Glorieux, FH; Klaushofer, K; Marini, JC; Rauch, F; Roschger, P, 2017)
"Ectopic calcinosis rarely occurs in systemic lupus erythematosus (SLE) patients."2.39Periarticular ectopic calcinosis probably due to 1 alpha-OH-vitamin D3 therapy, and successful treatment with bisphosphonate compound in a patient with systemic lupus erythematosus. ( Ishikawa, H; Ito, O; Kasukawa, R; Kurokawa, M; Miyata, M; Nishimaki, T; Sekine, H; Watanabe, S, 1996)
"Juvenile dermatomyositis is a rare systemic autoimmune disease wth calcinosis as its hallmark sequelae."1.56Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis. ( Dash, M; Giri, S; Panda, M; Parida, JR, 2020)
"Pamidronate (PAM) has been widely used for this purpose because of its high binding affinity toward bone and remarkable therapeutic effects."1.42Charge and hydrophobicity effects of NIR fluorophores on bone-specific imaging. ( Bao, K; Choi, HS; Gibbs, SL; Gravier, J; Hyun, H; Lee, JH; Nasr, KA, 2015)
"A 7-year-old girl with juvenile dermatomyositis developed severe calcinosis, despite an extensive medication regimen."1.40Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. ( Martillotti, J; Moote, D; Zemel, L, 2014)
"A 14-year-old girl with juvenile dermatomyositis developed extensive and debilitating calcinosis, unresponsive to colchicine, while muscle involvement subsided."1.36Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. ( Abdessemed, A; Haddouche, A; Ladjouze-Rezig, A; Slimani, S, 2010)
" In the present study, we demonstrated the effects of vitamin K(2) alone or in combination with pamidronate in an arterial calcification model induced using inorganic phosphate in cultured bovine aortic smooth muscle cells (BASMCs)."1.34Treatment with vitamin k(2) combined with bisphosphonates synergistically inhibits calcification in cultured smooth muscle cells. ( Saito, E; Sato, F; Seyama, Y; Sugitani, H; Wachi, H, 2007)
"Cytostatic treatment of multiple myeloma in combination with repetitive i."1.29Reversible metastatic pulmonary calcification in a patient with multiple myeloma. ( Frickhofen, N; Friedrich, JM; Hoffmeister, A; Mattfeldt, T; Merkle, E; Prümmer, O; Weber, CK, 1996)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19904 (15.38)18.7374
1990's9 (34.62)18.2507
2000's6 (23.08)29.6817
2010's6 (23.08)24.3611
2020's1 (3.85)2.80

Authors

AuthorsStudies
Giri, S1
Parida, JR1
Dash, M1
Panda, M1
Blouin, S1
Fratzl-Zelman, N1
Glorieux, FH1
Roschger, P1
Klaushofer, K1
Marini, JC1
Rauch, F1
Martillotti, J1
Moote, D1
Zemel, L1
Palaniappan, P1
Lionel, AP1
Kumar, S1
Bao, K1
Nasr, KA1
Hyun, H1
Lee, JH1
Gravier, J1
Gibbs, SL1
Choi, HS1
Lomashvili, KA1
Monier-Faugere, MC1
Wang, X1
Malluche, HH1
O'Neill, WC1
Neven, EG1
De Broe, ME1
D'Haese, PC1
Slimani, S1
Abdessemed, A1
Haddouche, A1
Ladjouze-Rezig, A1
Bayou, F1
Belajouza, C1
Boussofara, L1
Ghariani, N1
Denguezli, M1
Bouajina, E1
Nouira, R1
Christidou, F1
Bamichas, G1
Stangou, M1
Natse, T1
Kalpakidis, V1
Sombolos, K1
Mayahara, M1
Sasaki, T1
Saito, E1
Wachi, H1
Sato, F1
Sugitani, H1
Seyama, Y1
Nimni, ME2
Hirsch, D1
Schoen, FJ4
Levy, RJ4
Weber, CK1
Friedrich, JM1
Merkle, E1
Prümmer, O1
Hoffmeister, A1
Mattfeldt, T1
Frickhofen, N1
Van Gelder, JM1
Breuer, E2
Schlossman, A1
Ornoy, A2
Mönkkönen, J1
Similä, J1
Klenner, T1
Stadler, H1
Krempien, B1
Patlas, N2
Golomb, G3
Miyata, M1
Kurokawa, M1
Watanabe, S1
Ishikawa, H1
Sekine, H1
Ito, O1
Nishimaki, T1
Kasukawa, R1
Patashnik, S1
Rabinovich, L1
Cohen, H1
Solomon, V1
Alferiev, IS1
Eidelman, N1
Hägele, G1
Phanish, MK1
Kallarackal, G1
Ravanan, R1
Lawson, TM1
Baboolal, K1
Webb, CL3
Nguyen, NM1
Ertl, D1
Villanueva, J1
Nimni, BS1
Jones, M1
Eidbo, EE1
Hilbert, SL1
Ferrans, VJ1
Clark, RE1
Benedict, JJ1
Linden, JA1
Fleisch, H1

Reviews

2 reviews available for pamidronate and Calcinosis

ArticleYear
Periarticular ectopic calcinosis probably due to 1 alpha-OH-vitamin D3 therapy, and successful treatment with bisphosphonate compound in a patient with systemic lupus erythematosus.
    Fukushima journal of medical science, 1996, Volume: 42, Issue:1-2

    Topics: Adult; Calcinosis; Diphosphonates; Female; Finger Joint; Humans; Hydroxycholecalciferols; Lupus Eryt

1996
[Biphosphonate as a therapeutic drug--experimental studies and clinical application].
    Therapeutische Umschau. Revue therapeutique, 1985, Volume: 42, Issue:6

    Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperpar

1985

Trials

1 trial available for pamidronate and Calcinosis

ArticleYear
Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2017, Volume: 32, Issue:9

    Topics: Adolescent; Bone Density; Calcinosis; Cancellous Bone; Child; Child, Preschool; Collagen Type I; Col

2017

Other Studies

23 other studies available for pamidronate and Calcinosis

ArticleYear
Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis.
    Indian pediatrics, 2020, 01-15, Volume: 57, Issue:1

    Topics: Calcinosis; Child; Child, Preschool; Dermatomyositis; Female; Fingers; Humans; Male; Pamidronate

2020
Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.
    Pediatric radiology, 2014, Volume: 44, Issue:1

    Topics: Bone Density Conservation Agents; Calcinosis; Child; Dermatomyositis; Diphosphonates; Female; Humans

2014
Successful treatment of calcinosis cutis in juvenile dermatomyositis with pamidronate.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:8

    Topics: Calcinosis; Child; Dermatomyositis; Diphosphonates; Dose-Response Relationship, Drug; Drug Administr

2014
Charge and hydrophobicity effects of NIR fluorophores on bone-specific imaging.
    Theranostics, 2015, Volume: 5, Issue:6

    Topics: Animals; Bone and Bones; Calcinosis; Diphosphonates; Female; Fluorescent Dyes; Hydrophobic and Hydro

2015
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
    Kidney international, 2009, Volume: 75, Issue:6

    Topics: Animals; Aortic Diseases; Bone and Bones; Bone Resorption; Calcification, Physiologic; Calcinosis; D

2009
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Kidney international, 2009, Volume: 75, Issue:6

    Topics: Animals; Aortic Diseases; Calcification, Physiologic; Calcinosis; Diphosphonates; Etidronic Acid; Hu

2009
Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.
    Joint bone spine, 2010, Volume: 77, Issue:1

    Topics: Adolescent; Bone Density Conservation Agents; Calcinosis; Calcium; Cholecalciferol; Dermatomyositis;

2010
[Aggressive universal calcinosis complicating dermatomyositis].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:11

    Topics: Adolescent; Anti-Bacterial Agents; Calcinosis; Combined Modality Therapy; Cutaneous Fistula; Dermato

2011
Tumoral calcinosis inducing systemic inflammatory response in a hemodialysis patient.
    Nephron, 2002, Volume: 92, Issue:2

    Topics: Aged; Calcinosis; Diphosphonates; Hip Joint; Hip Prosthesis; Humans; Inflammation; Male; Pamidronate

2002
Cellular mechanism of inhibition of osteoclastic resorption of bone and calcified cartilage by long-term pamidronate administration in ovariectomized mature rats.
    The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology, 2003, Volume: 274, Issue:1

    Topics: Acid Phosphatase; Animals; Apoptosis; Bone Resorption; Calcinosis; Cartilage; Diphosphonates; Dose-R

2003
Treatment with vitamin k(2) combined with bisphosphonates synergistically inhibits calcification in cultured smooth muscle cells.
    Journal of atherosclerosis and thrombosis, 2007, Volume: 14, Issue:6

    Topics: Calcinosis; Cells, Cultured; Diphosphonates; Drug Synergism; Drug Therapy, Combination; Humans; Musc

2007
Biochemistry of bone induction and dystrophic calcification.
    Clinics in plastic surgery, 1994, Volume: 21, Issue:3

    Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Bone Demineralization Technique; Bone Diseases, Met

1994
Effects of metallic ions and diphosphonates on inhibition of pericardial bioprosthetic tissue calcification and associated alkaline phosphatase activity.
    Biomaterials, 1993, Volume: 14, Issue:5

    Topics: Alkaline Phosphatase; Animals; Bioprosthesis; Calcinosis; Cattle; Diphosphonates; Etidronic Acid; Gl

1993
Reversible metastatic pulmonary calcification in a patient with multiple myeloma.
    Annals of hematology, 1996, Volume: 72, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Calcinosis; Diphosphonates; Fema

1996
In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages.
    Journal of pharmaceutical sciences, 1997, Volume: 86, Issue:3

    Topics: Animals; Bioprosthesis; Bone Resorption; Calcinosis; Carcinoma 256, Walker; Cell Line; Cell Survival

1997
Preparation and evaluation of chitosan microspheres containing bisphosphonates.
    Journal of drug targeting, 1997, Volume: 4, Issue:6

    Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Resorption; Calcinosis; Cattle; Chitin; Chito

1997
Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders.
    Pharmaceutical research, 1998, Volume: 15, Issue:4

    Topics: Alendronate; Animals; Anti-Inflammatory Agents; Betaine; Bone and Bones; Bone Resorption; Calcinosis

1998
Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a haemodialysis patient: successful treatment using intravenous pamidronate.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:10

    Topics: Adult; Anti-Inflammatory Agents; Arthritis; C-Reactive Protein; Calcinosis; Diphosphonates; Fever; H

2000
Calcification of allograft aortic wall in a rat subdermal model. Pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations.
    The American journal of pathology, 1992, Volume: 141, Issue:2

    Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Aorta; Aortic Diseases; Calcinosis; Chlori

1992
Inhibition of ectopic calcification of glutaraldehyde crosslinked collagen and collagenous tissues by a covalently bound diphosphonate (APD).
    The American journal of cardiovascular pathology, 1990, Volume: 3, Issue:3

    Topics: Animals; Biocompatible Materials; Bioprosthesis; Calcinosis; Cattle; Diphosphonates; Heart Valve Pro

1990
Covalent binding of aminopropanehydroxydiphosphonate to glutaraldehyde residues in pericardial bioprosthetic tissue: stability and calcification inhibition studies.
    Experimental and molecular pathology, 1989, Volume: 50, Issue:3

    Topics: Aldehydes; Animals; Bioprosthesis; Calcinosis; Diphosphonates; Disease Models, Animal; Glutaral; Hea

1989
Anticalcification treatments of bioprosthetic heart valves: in vivo studies in sheep.
    Journal of cardiac surgery, 1989, Volume: 4, Issue:1

    Topics: Acrylic Resins; Animals; Biocompatible Materials; Bioprosthesis; Calcinosis; Diphosphonates; Heart V

1989
Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups.
    The Annals of thoracic surgery, 1988, Volume: 46, Issue:3

    Topics: Aldehydes; Animals; Aortic Valve Stenosis; Bioprosthesis; Calcinosis; Cattle; Diphosphonates; Diseas

1988